Marjolein van Heerden

1.1k total citations
32 papers, 527 citations indexed

About

Marjolein van Heerden is a scholar working on Molecular Biology, Oncology and Pharmaceutical Science. According to data from OpenAlex, Marjolein van Heerden has authored 32 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pharmaceutical Science. Recurrent topics in Marjolein van Heerden's work include Advancements in Transdermal Drug Delivery (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Marjolein van Heerden is often cited by papers focused on Advancements in Transdermal Drug Delivery (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Marjolein van Heerden collaborates with scholars based in Belgium, United States and Netherlands. Marjolein van Heerden's co-authors include Filip Cuyckens, Patrick Sterkens, Guy Van den Mooter, Pieter Annaert, Marc De Meulder, J. Eric McDuffie, Sandra De Jonghe, Ron M. A. Heeren, Stijn J. M. Van Malderen and Frank Vanhaecke and has published in prestigious journals such as Analytical Chemistry, Journal of Controlled Release and Analytica Chimica Acta.

In The Last Decade

Marjolein van Heerden

27 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjolein van Heerden Belgium 15 172 122 93 44 43 32 527
Erik P. Sandefer United States 14 292 1.7× 55 0.5× 33 0.4× 80 1.8× 40 0.9× 27 577
K.J. Palin United Kingdom 12 323 1.9× 202 1.7× 29 0.3× 40 0.9× 31 0.7× 22 737
Renaud Respaud France 19 73 0.4× 266 2.2× 35 0.4× 85 1.9× 113 2.6× 34 937
Philipp Uhl Germany 17 150 0.9× 424 3.5× 40 0.4× 85 1.9× 70 1.6× 58 876
Peter C. Seville United Kingdom 18 532 3.1× 179 1.5× 40 0.4× 39 0.9× 39 0.9× 26 1.1k
Tomás Sou Sweden 13 192 1.1× 121 1.0× 20 0.2× 28 0.6× 72 1.7× 17 555
Tara Dyson United States 3 363 2.1× 229 1.9× 19 0.2× 84 1.9× 77 1.8× 3 1.1k
Chaeho Moon United States 17 149 0.9× 162 1.3× 19 0.2× 110 2.5× 44 1.0× 29 587
Sanil D. Singh South Africa 19 139 0.8× 257 2.1× 67 0.7× 239 5.4× 172 4.0× 45 907
Wouter F. Tonnis Netherlands 13 193 1.1× 192 1.6× 15 0.2× 73 1.7× 99 2.3× 15 555

Countries citing papers authored by Marjolein van Heerden

Since Specialization
Citations

This map shows the geographic impact of Marjolein van Heerden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjolein van Heerden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjolein van Heerden more than expected).

Fields of papers citing papers by Marjolein van Heerden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjolein van Heerden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjolein van Heerden. The network helps show where Marjolein van Heerden may publish in the future.

Co-authorship network of co-authors of Marjolein van Heerden

This figure shows the co-authorship network connecting the top 25 collaborators of Marjolein van Heerden. A scholar is included among the top collaborators of Marjolein van Heerden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjolein van Heerden. Marjolein van Heerden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Flinders, Bryn, Bhanu Singh, Heng‐Keang Lim, et al.. (2025). Investigation into Drug-Induced Liver Damage Using Multimodal Mass Spectrometry Imaging. Journal of the American Society for Mass Spectrometry. 36(2). 265–276.
3.
Snoeys, Jan, Marjolein van Heerden, An Van den Bergh, et al.. (2025). Human organotypic colon in vitro microtissue: unveiling a new window into colonic drug disposition. European Journal of Pharmaceutical Sciences. 209. 107025–107025. 2 indexed citations
4.
Daneshmand, Siamak, et al.. (2025). PENELOPE: TISSUE PENETRATION OF GEMCITABINE PHOSPHATE METABOLITES FOLLOWING TAR-200 ADMINISTRATION VS STANDARD INTRAVESICAL INSTILLATION IN MINIPIGS. Urologic Oncology Seminars and Original Investigations. 43(3). 48–48.
5.
6.
Heerden, Marjolein van, et al.. (2024). Characteristics of heart failure with a preserved ejection fraction in black South African patients. IJC Heart & Vasculature. 52. 101408–101408. 3 indexed citations
7.
Schulz, Stephanie, Marjolein van Heerden, Pieter Verboven, et al.. (2023). Intestinal organoids as an in vitro platform to characterize disposition, metabolism, and safety profile of small molecules. European Journal of Pharmaceutical Sciences. 188. 106481–106481. 19 indexed citations
8.
9.
Heerden, Marjolein van, et al.. (2019). In vitro evaluation of poloxamer in situ forming gels for bedaquiline fumarate salt and pharmacokinetics following intramuscular injection in rats. International Journal of Pharmaceutics X. 1. 100016–100016. 32 indexed citations
10.
Erkens, Tim, et al.. (2018). Translational safety biomarkers of colonic barrier integrity in the rat. Journal of Applied Toxicology. 38(10). 1282–1292. 2 indexed citations
11.
Flinders, Bryn, Marjolein van Heerden, Filip Cuyckens, et al.. (2018). Cross-Species Molecular Imaging of Bile Salts and Lipids in Liver: Identification of Molecular Structural Markers in Health and Disease. Analytical Chemistry. 90(20). 11835–11846. 25 indexed citations
12.
13.
Heerden, Marjolein van, Marc De Meulder, Stefaan Rossenu, et al.. (2016). The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension. Journal of Controlled Release. 230. 95–108. 50 indexed citations
14.
Feyen, Bianca, et al.. (2016). “All pigs are equal” Does the background data from juvenile Göttingen minipigs support this?. Reproductive Toxicology. 64. 105–115. 5 indexed citations
15.
Acker, Thibaut Van, Stijn J. M. Van Malderen, Marjolein van Heerden, et al.. (2016). High-resolution laser ablation-inductively coupled plasma-mass spectrometry imaging of cisplatin-induced nephrotoxic side effects. Analytica Chimica Acta. 945. 23–30. 65 indexed citations
16.
Saarinen, Jukka, Antti Isomäki, Leonid Khriachtchev, et al.. (2015). Multimodal non-linear optical imaging for the investigation of drug nano-/microcrystal–cell interactions. European Journal of Pharmaceutics and Biopharmaceutics. 96. 338–348. 16 indexed citations
17.
Schaepdrijver, Luc De, et al.. (2015). Juvenile animal testing of hydroxypropyl-β-cyclodextrin in support of pediatric drug development. Reproductive Toxicology. 56. 87–96. 10 indexed citations
18.
Heerden, Marjolein van, Tim Erkens, Sandra De Jonghe, et al.. (2015). Modeling the Time Course of the Tissue Responses to Intramuscular Long-acting Paliperidone Palmitate Nano-/Microcrystals and Polystyrene Microspheres in the Rat. Toxicologic Pathology. 44(2). 189–210. 37 indexed citations
19.
Schauwer, Catharina De, Koen Chiers, Laurence Lefère, et al.. (2012). Hydrallantois in the Mare – A Report of Five Cases. Reproduction in Domestic Animals. 48(1). e1–6. 7 indexed citations
20.
Vercruysse, J., David Rollinson, Marjolein van Heerden, & V. R. Southgate. (2003). On the longevity of Schistosoma curassoni. Journal of Helminthology. 77(1). 89–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik P. Sandefer Breakdown of academic impact, for papers by K.J. Palin Breakdown of academic impact, for papers by Renaud Respaud Breakdown of academic impact, for papers by Philipp Uhl Breakdown of academic impact, for papers by Peter C. Seville Breakdown of academic impact, for papers by Tomás Sou Breakdown of academic impact, for papers by Tara Dyson Breakdown of academic impact, for papers by Chaeho Moon Breakdown of academic impact, for papers by Sanil D. Singh Breakdown of academic impact, for papers by Wouter F. Tonnis
Rankless by CCL
2026